These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33309828)

  • 1. Establishment of universal human embryonic stem cell lines.
    Kong M; Zhou D
    Immunol Lett; 2021 Feb; 230():59-62. PubMed ID: 33309828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for preventing immunologic rejection of transplanted human embryonic stem cells.
    Cabrera CM; Cobo F; Nieto A; Concha A
    Cytotherapy; 2006; 8(5):517-8. PubMed ID: 17050257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-the-Shelf, Immune-Compatible Human Embryonic Stem Cells Generated Via CRISPR-Mediated Genome Editing.
    Kim A; Lee KG; Kwon Y; Lee KI; Yang HM; Habib O; Kim J; Kim ST; Kim SJ; Kim JS; Hwang DY
    Stem Cell Rev Rep; 2021 Jun; 17(3):1053-1067. PubMed ID: 33423156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
    Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
    J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations.
    Zimmermann A; Preynat-Seauve O; Tiercy JM; Krause KH; Villard J
    Stem Cells Dev; 2012 Sep; 21(13):2364-73. PubMed ID: 22559254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoiding immunological rejection in regenerative medicine.
    Bolton EM; Bradley JA
    Regen Med; 2015; 10(3):287-304. PubMed ID: 25933238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes.
    Lee JE; Kang MS; Park MH; Shim SH; Yoon TK; Chung HM; Lee DR
    Cell Transplant; 2010; 19(11):1383-95. PubMed ID: 20587141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation.
    Liu P; Souma T; Wei AZ; Xie X; Luo X; Jin J
    J Vis Exp; 2017 Sep; (127):. PubMed ID: 28930983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Immunogenicity of Keratinocytes Derived from Human Embryonic Stem Cells.
    Shen J; Zeng X; Lv H; Jin Y; Liu Y; Lian W; Huang S; Zang Q; Zhang Q; Xu J
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal cell donor lines: A review of the current research.
    Simpson A; Hewitt AW; Fairfax KA
    Stem Cell Reports; 2023 Nov; 18(11):2038-2046. PubMed ID: 37832541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching.
    Taylor CJ; Bolton EM; Pocock S; Sharples LD; Pedersen RA; Bradley JA
    Lancet; 2005 Dec; 366(9502):2019-25. PubMed ID: 16338451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matching for Human Leukocyte Antigens (HLA) in corneal transplantation - to do or not to do.
    van Essen TH; Roelen DL; Williams KA; Jager MJ
    Prog Retin Eye Res; 2015 May; 46():84-110. PubMed ID: 25601193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
    Deuse T; Seifert M; Tyan D; Tsao PS; Hua X; Velden J; Eiermann T; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
    J Cell Sci; 2011 Sep; 124(Pt 17):3029-37. PubMed ID: 21878509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HLA antibodies in regenerative medicine stem cell therapy.
    Charron D; Suberbielle-Boissel C; Tamouza R; Al-Daccak R
    Hum Immunol; 2012 Dec; 73(12):1287-94. PubMed ID: 22789622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Population Genetics in Solid Organ Transplantation.
    Kransdorf EP; Pando MJ; Gragert L; Kaplan B
    Transplantation; 2017 Sep; 101(9):1971-1976. PubMed ID: 28832450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Study on Human Leukocyte Antigen Types and Haplotypes in a South African Population.
    Gandini A; Mampeule N; Jugwanth S; Gededzha MP; Mayne E
    Arch Pathol Lab Med; 2021 Apr; 145(4):441-447. PubMed ID: 32960949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of human leukocyte antigen immunogenicity: current methods, challenges and opportunities.
    Copley HC; Elango M; Kosmoliaptsis V
    Curr Opin Organ Transplant; 2018 Aug; 23(4):477-485. PubMed ID: 29870434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.